0001778959-20-000001.txt : 20200622 0001778959-20-000001.hdr.sgml : 20200622 20200622092145 ACCESSION NUMBER: 0001778959-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200622 DATE AS OF CHANGE: 20200622 EFFECTIVENESS DATE: 20200622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revere Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001778959 IRS NUMBER: 814687513 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-342452 FILM NUMBER: 20977354 BUSINESS ADDRESS: STREET 1: 36 ORVIS ROAD CITY: ARLINGTON STATE: MA ZIP: 02474 BUSINESS PHONE: 781-718-9033 MAIL ADDRESS: STREET 1: 36 ORVIS ROAD CITY: ARLINGTON STATE: MA ZIP: 02474 D/A 1 primary_doc.xml X0708 D/A LIVE 0001778959 Revere Pharmaceuticals Inc. 36 ORVIS ROAD ARLINGTON MA MASSACHUSETTS 02474 781-718-9033 DELAWARE None None Corporation true 2016 Ian Robert Silverman 36 Orvis Road Arlington MA MASSACHUSETTS 02474 Executive Officer Director Jedd Levine 36 Orvis Road Arlington MA MASSACHUSETTS 02474 Executive Officer Director Kollol Pal 36 Orvis Road Arlington MA MASSACHUSETTS 02474 Director Pharmaceuticals Decline to Disclose 06b true 0001778959-19-000001 2019-06-11 true true false 0 3487668 1587363 1900305 false 30 0 0 0 false Revere Pharmaceuticals Inc. /s/ Ian Robert Silverman Ian Robert Silverman President and Chief Executive Officer 2020-06-22